SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,067.81 685.34
( 0.95%)

Global Indices

Nasdaq

51,284.68 86.72
(0.17%)

Dow Jones

7,793.50 49.78
(0.64%)

Hang Seng

70,716.70 769.84
(1.10%)

Nikkei 225

10,543.25 45.31
(0.43%)

Forex

USD-INR

95.96 -0.21
(-0.22%)

EUR-INR

107.98 -0.51
(-0.47%)

GBP-INR

127.02 -0.14
(-0.11%)

JPY-INR

0.61 0.00
(-0.10%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Gland Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

543245

INE068V01023

655.111941

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLAND

34.03

48067.66

EPS(TTM)

Face Value()

Div & Yield %

85.6

0.69

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	197.42	130.11	50.27	10.95	17.92	18.21
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	197.42	130.11	50.27	10.95	17.92	18.21
Other Income	2.16	0.66	3.15	2.87	0.69	0.43
Stock Adjustments	12.43	4.05	5.97	-1.49	1.03	-0.44
Total Income	212.01	134.82	59.39	12.33	19.64	18.20
EXPENDITURE :
Raw Materials	121.93	78.99	35.87	6.59	11.74	8.17
Power & Fuel Cost	7.24	5.83	2.98	0.68	0.76	0.85
Employee Cost	6.53	4.83	2.87	1.10	1.62	1.56
Other Manufacturing Expenses	8.27	5.55	2.36	0.48	0.83	0.82
Selling & Administrative Expenses	6.59	2.22	2.12	0.91	3.16	4.30
Miscellaneous Expenses	6.98	1.10	4.56	0.65	0.02	0.10
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	157.54	98.51	50.77	10.40	18.14	15.80
Operating Profit	54.47	36.32	8.62	1.93	1.50	2.41
Interest	3.12	1.75	0.35	0.96	0.92	0.96
Gross Profit	51.35	34.57	8.27	0.97	0.58	1.45
Depreciation	3.44	2.45	1.14	0.89	1.11	1.16
Profit Before Tax	47.91	32.12	7.13	0.08	-0.53	0.29
Tax	14.32	8.21	1.75	0.05	0.00	0.00
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-1.63	0.00	-0.03	0.00	0.41	0.18
Reported Net Profit	35.22	23.91	5.41	0.03	-0.94	0.11
Extraordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Net Profit	35.22	23.91	5.41	0.03	-0.94	0.11
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance brought forward	24.57	0.67	-1.72	-1.74	-0.80	-0.91
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	1.25	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	58.54	24.57	3.70	-1.72	-1.74	-0.80
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	3.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.03	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	1.41	0.96	3.59	0.04	-1.41	0.16
Earnings Per Share(Adj)-Unit Curr	0.82	0.06	0.21	0.00	-0.08	0.01
Book Value-Unit Curr	4.44	3.08	23.55	19.04	18.99	20.40
Book Value(Adj)-Unit Curr	2.59	0.18	1.37	1.11	1.11	1.19

73,067.81 685.34 ( 0.95%)

51,284.68 86.72 (0.17%)

7,793.50 49.78 (0.64%)

70,716.70 769.84 (1.10%)

10,543.25 45.31 (0.43%)

95.96 -0.21 (-0.22%)

107.98 -0.51 (-0.47%)

127.02 -0.14 (-0.11%)

0.61 0.00 (-0.10%)